alexa Accuracy of MRI for Prediction of Response to Neo-Adjuvant Chemotherapy in Triple Negative Breast Cancer Compared to Other Molecular Types
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Accuracy of MRI for Prediction of Response to Neo-Adjuvant Chemotherapy in Triple Negative Breast Cancer Compared to Other Molecular Types

Bansal Gaurav Jyoti*

Breast Centre Llandough, University Hospital of Llandough, Penlan Road, Llandough, CF64 2XX, UK

*Corresponding Author:
Bansal Gaurav Jyoti
Breast Centre Llandough
University Hospital of Llandough
Penlan Road, Llandough
CF64 2XX, UK
Tel: +44 (0) 7952285450
E-mail: [email protected]

Received Date: November 23, 2015 Accepted Date: December 15, 2015 Published Date: December 21, 2015

Citation: Jyoti BS (2015) Accuracy of MRI for Prediction of Response to Neo-Adjuvant Chemotherapy in Triple Negative Breast Cancer Compared to Other Molecular Types. Chemo Open Access 5:175. doi: 10.4172/2167-7700.1000175

Copyright: © 2015 Jyoti BS. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Abstract Purpose: The aim of this study was to compare the accuracy of MRI for prediction of response to Neo-adjuvant chemotherapy in Triple negative (TN) breast cancer, with respect to other molecular types. Materials and methods: There were a total of 1610 breast cancers diagnosed between March 2009 and August 2014, out of which 82 patients underwent MRI before and after neo-adjuvant chemotherapy but just before surgery. Triple negative cancers were analysed with respect to others subtypes. Accuracy of MRI for prediction of pathological complete response was compared between different subtypes, by obtaining ROC curves. SPSS (version 21) was used for all data analysis with p value of 0.05 as statistically significant. Results: Out of 82 patients, 29 were Luminal (HR+/HER2 -), 23 were triple negative (HR-, HER2-), 11 HER2 positive (HR-, HER2+) and 19 were of hybrid subtype (HR+/HER2+). Triple negative cancers presented as masses on the pre-chemotherapy MRI scan, were grade 3 on histopathology and show concentric shrinkage following chemotherapy. Triple negative cancers were more likely to have both imaging and pathological complete response following chemotherapy (p=0.055) in contrast to Luminal cancers, which show residual cancer. ROC curves were constructed for prediction of PCR by post chemotherapy MR. For the triple negative sub-group, MR had sensitivity of 0.745 and specificity of 0.700 (p=0.035), with an area under curve (AUC) of 0.745(95% CI 0.526-0.965), which was significantly better compared to other subtypes. Conclusion: Triple negative breast cancers present as masses and show concentric shrinkage following chemotherapy. MRI is most sensitive and specific in predicting response to chemotherapy in the TN group, compared to others subtypes. MRI underestimates residual disease in Luminal cancers.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version